 |
|
|
|
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
|
|
 |
|
|
A January 2007 report in The New England Journal of Medicine stated that the hyperprolactinemia medication Dostinex (cabergoline) is significantly associated with cardiac valve disease. The study found that 29 percent of the patients taking Dostinex have damaged heart valves. Only 6 percent of the control subjects (who were not taking the drug) suffered from this. Pfizer Inc., the maker of the drug, identifies the mild warning of this significant risk as only a “precaution.”
Dostinex is used to treat excess secretion of the hormone prolactin in a disorder known as hyperprolactinemia. It is also used to treat Parkinson’s disease in Europe, but was approved by the FDA in 1996 only for the treatment of hyperprolactinemia.
In December 2006, Pfizer had added a precautionary warning to Dostinex labels, a minor change that would not be obvious to prescribing doctors but that did identify the potential for cardiac damage. If you have suffered any heart problems and have used Dostinex, please obtain a Free Consultation by submitting our online form, or by calling 1-800-543-9859.
Here are some other perscription drugs that have recently been recalled or have been linked to illnesses in users:
|
|
 |
|
|
|
|
|
| __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
Don’t Hesitate to Contact Robert Peirce & Associates, P.C.
For a Free and Confidential Consultation
Robert Peirce & Associates, P.C.
2500 Gulf Tower, 707 Grant Street, Pittsburgh, PA 15219
P: 1-800-543-9859 F: 412-281-4229 |
| |
| Potential clients: Please be advised that submitting the "free consultation" form through our online system does not commit you to hiring our firm, and does not mean that you have retained an attorney for your potential case. The inquiry form will be reviewed by an attorney, and someone from Robert Peirce & Associates, P.C. will contact you to discuss the facts of your potential case. No attorney-client relationship is formed until a fee agreement is signed. We cannot guarantee the security of this site, and are not responsible for storing sensitive information. |
|
|
